Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

mogamulizumab-kpkc

mogamulizumab-kpkc
  • Restricted Poteligeo --> restricted to outpatient oncology where at least one prior systemic therapy has failed.
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Poteligeo SOLUTION, INTRAVENOUS 20 mg/5 mL      
Comments:

Restricted to use by oncology in outpatient setting, only if at least one prior systemic therapy has failed.

Reviewed: 22 Jan 19 (Poteligeo)

Last updated: Jan. 22, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved